MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 41 to 60 of 166,322 approvalsPage 3 of 8317

Mecobalamin Tablets

Approval Number: 国药准字H20254466
Registration: Jun 3, 2025

Ibuprofen Suspension

Approval Number: 国药准字H20254439
Registration: Jun 3, 2025

Diclofenac Diethylamine Emulgel

Approval Number: 国药准字H20254434
Registration: Jun 3, 2025

Cefprozil for Suspension

Approval Number: 国药准字H20254445
Registration: Jun 3, 2025

Timolol Maleate Eye Drops

Approval Number: 国药准字H20254418
Registration: Jun 3, 2025

Oxacillin Sodium for Injection

Approval Number: 国药准字H20254447
Registration: Jun 3, 2025

Potassium Chloride Granules

Approval Number: 国药准字H20254413
Registration: Jun 3, 2025

Nifedipine Sustained-release Tablets(II)

Approval Number: 国药准字H20254425
Registration: Jun 3, 2025

Lidocaine and Prilocaine Cream

Approval Number: 国药准字H20254428
Registration: Jun 3, 2025

Carbazochrome Sodium Sulfonate Injection

Approval Number: 国药准字H20254455
Registration: Jun 3, 2025

Levodropropizine Oral Solution

Approval Number: 国药准字H20254461
Registration: Jun 3, 2025

Carbazochrome Sodium Sulfonate Tablets

Approval Number: 国药准字H20254419
Registration: Jun 3, 2025

Minoxidil Liniment

Approval Number: 国药准字H20254406
Registration: Jun 3, 2025

Ibuprofen Suspension

Approval Number: 国药准字H20254440
Registration: Jun 3, 2025

Formoterol fumarate Inhalation Solution

Approval Number: 国药准字H20254433
Registration: Jun 3, 2025

Cycloserine Capsules

Approval Number: 国药准字H20254423
Registration: Jun 3, 2025

Polymyxini B Sulphas for Injection

Approval Number: 国药准字H20254404
Registration: Jun 3, 2025

Sodium Hyaluronate Eye Drops

Approval Number: 国药准字H20254427
Registration: Jun 3, 2025

Levodropropizine Oral Solution

Approval Number: 国药准字H20254462
Registration: Jun 3, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.